Log in
Log in
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
Sign up
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     

JOHNSON & JOHNSON

(JNJ)
  Report
Delayed Nyse  -  04:00:02 2023-03-31 pm EDT
155.00 USD   +1.02%
03/30Janssen Pharmaceutical - New RYBREVANT Data Showed Long-Term Clinical Response and Safety in Patients with Advanced Non-Small Cell Lung Cancer with EGFR Exon 20 Insertion Mutations Who Have Failed Prior Platinum-Based Chemotherapy
AQ
03/30Janssen Provides Portfolio Update
AQ
03/29Sector Update: Health Care Stocks Steady Late Wednesday
MT
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisionsFunds 
 SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies
Most relevant news about JOHNSON & JOHNSON
03/30Janssen Pharmaceutical - New RYBREVANT Data Showed Long-Term Clinical Response and Safe..
AQ
03/30Janssen Provides Portfolio Update
AQ
03/29UBS Adjusts Johnson & Johnson Price Target to $164 From $175, Maintains Neutral Rating
MT
03/29Johnson & Johnson Unit to Discontinue Respiratory Syncytial Virus Vaccine Program in Ad..
MT
03/23Janssen Pharmaceutical Says Health Canada Authorizes Expanded Use of Imbruvica in Combi..
MT
03/22Talc Plaintiffs Will Press to Reopen Courthouse Doors
PR
03/20The Texas Two-Step Is Alive And Well
AQ
03/20Janssen Pharmaceutical - TREMFYA Real-World Data Analyses Show Greater Treatment Persis..
AQ
03/15Johnson & Johnson to Host Investor Conference Call on First-Quarter Results
BU
03/15Johnson & Johnson Unit Janssen Says Pre-Clinical Results Showed Dengue Candidate Drug D..
MT
03/15Janssen Announces Novel Dengue Antiviral Demonstrates Efficacy in Pre-Clinical Data Pub..
BU
03/15Johnson & Johnson Receives Shareholder Proposal from Mercy Investment Services Inc
CI
03/15Johnson & Johnson Receives Shareholder Proposal from Vermont Pension Investment Commiss..
CI
03/15Johnson & Johnson Receives Shareholder Proposal from Oxfam America Inc
CI
03/15Johnson & Johnson Receives Shareholder Proposal from Hal Scott/The Doris Behr 2012 Irre..
CI
More most relevant news
All news about JOHNSON & JOHNSON
03/30Janssen Pharmaceutical - New RYBREVANT Data Showed Long-Term Clinical Response and Safe..
AQ
03/30Janssen Provides Portfolio Update
AQ
03/29Sector Update: Health Care Stocks Steady Late Wednesday
MT
03/29Sector Update: Health Care Stocks Mixed on Wednesday Afternoon
MT
03/29UBS Adjusts Johnson & Johnson Price Target to $164 From $175, Maintains Neutral Rating
MT
03/29Johnson & Johnson Unit to Discontinue Respiratory Syncytial Virus Vaccine Program in Ad..
MT
03/29STAAR Surgical Appoints Warren Foust as Chief Operating Officer
MT
03/29Virtual Incision Expands Leadership Team as it Prepares for New Market Growth
AQ
03/23Janssen Pharmaceutical Says Health Canada Authorizes Expanded Use of Imbruvica in Combi..
MT
03/22Talc Plaintiffs Will Press to Reopen Courthouse Doors
PR
More news
News in other languages on JOHNSON & JOHNSON
03/29Mise à jour sectorielle : Les valeurs de la santé restent stable..
03/29Mise à jour sectorielle : les titres du secteur de la santé sont..
03/29J&J : Janssen abandonne son projet de vaccin contre le RSV
03/29Johnson & Johnson Unit interrompt son programme de vaccination des adultes contre le vi..
03/29STAAR Surgical nomme Warren Foust au poste de directeur des opérations
03/23Janssen Pharmaceutical annonce que Santé Canada autorise l'utilisation élargie d'Imbruv..
03/17J&J : résultats positifs pour Tremfya contre le psoriasis
03/15Janssen, une unité de Johnson & Johnson, déclare que les résultats précliniques montren..
03/15Halozyme Therapeutics réaffirme ses prévisions de recettes pour 2023 après la révocatio..
03/15Johnson & Johnson reçoit une proposition d'actionnaire de Hal Scott/The Doris Behr 2012..
More news
Analyst Recommendations on JOHNSON & JOHNSON
03/29UBS Adjusts Johnson & Johnson Price Target to $164 From $175, Maintains Neutral Rating
MT
03/01Guggenheim Initiates Johnson & Johnson at Neutral With $161 Price Target
MT
01/25Morgan Stanley Adjusts Price Target on Johnson & Johnson to $180 From $176, Maintains E..
MT
01/25Atlantic Equities Adjusts Johnson & Johnson's Price Target to $168 From $160, Keeps Neu..
MT
01/20SVB Securities Adjusts Price Target on Johnson & Johnson to $186 From $194, Maintains O..
MT
More recommendations
Press releases
03/30Janssen Pharmaceutical - New RYBREVANT Data Showed Long-Term Clinical Response and Safe..
AQ
03/30Janssen Provides Portfolio Update
AQ
03/29Virtual Incision Expands Leadership Team as it Prepares for New Market Growth
AQ
03/22Talc Plaintiffs Will Press to Reopen Courthouse Doors
PR
03/20The Texas Two-Step Is Alive And Well
AQ
More press releases
Upcoming event on JOHNSON & JOHNSON
1 MarketScreener is worth more than 1000 Influencers!
100% Free Registration
fermer